Cargando…
Approaches, Progress, and Challenges to Hepatitis C Vaccine Development
Risk factors for hepatitis C virus (HCV) infection vary, and there were an estimated 1.75 million new cases worldwide in 2015. The World Health Organization aims for a 90% reduction in new HCV infections by 2030. An HCV vaccine would prevent transmission, regardless of risk factors, and significantl...
Autores principales: | Bailey, Justin R., Barnes, Eleanor, Cox, Andrea L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
W.B. Saunders
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340767/ https://www.ncbi.nlm.nih.gov/pubmed/30268785 http://dx.doi.org/10.1053/j.gastro.2018.08.060 |
Ejemplares similares
-
Editorial: Current Progress and Challenges in the Development of a B Cell Based Hepatitis C Virus Vaccine
por: Foung, Steven K. H., et al.
Publicado: (2018) -
The case for a universal hepatitis C vaccine to achieve hepatitis C elimination
por: Scott, Nick, et al.
Publicado: (2019) -
Computational Approaches and Challenges to Developing Universal Influenza Vaccines
por: Qiu, Xueting, et al.
Publicado: (2019) -
Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies
por: Drummer, Heidi E.
Publicado: (2014) -
Therapeutic vaccination for treatment of chronic hepatitis B
por: Cargill, Tamsin, et al.
Publicado: (2021)